Facebook
Twitter
LinkedIn
ForwardTreating OUD During Pregnancy: BJC HealthCare’s CARE in Pregnancy Program
This webinar will describe one organizations approach to implementing a substance abuse treatment program for pregnant women. The CARE (Clinic for Acceptance, Recovery and Empowerment) program offers prenatal care substance abuse treatment and extended post-partum support for pregnant women with OUD. The presentation will review the critical elements of the program, the challenges and barriers to providing prenatal OUD treatment and the holistic approach to addressing the psychosocial needs of the patients.
Target Audience
Physician
Nursing
Pharmacist
Learning Objectives
- Review the epidemiology and pathology of opioid use disorder in women's health and obstetrical care
- Discuss the recommendations of OUD treatment in pregnancy and postpartum, and the patient-centered approach we take in CARE
- Review the critical elements required in CARE in order to overcome the challenges and barriers of prenatal OUD treatment
- Review the holistic approach of the CARE program and discuss how the psychosocial needs of our patients are addressed.
Additional Information
| Attachment | Size |
|---|---|
 Helpful Tips for Users | 23.29 KB |
| Information for CE Credit | 125 KB |
 CARE in Pregnancy Program Presentation | 19.52 MB |
Relevant financial relationships: None of the planning committee and/or presenters have anything to disclose.
Planning committee members
Jeannie Kelly, MD, MS
Assistant Professor of OBGYN
Division of Maternal Fetal Medicine
Washington University in St. Louis
Medical Director, Obstetrical Inpatient Services
Medical Director, C.A.R.E. in Pregnancy
Washington University in St. Louis
Jim Lichauer, PharmD, BCPS, FASHP
PI Program Director, Pharmacy
Vizient
Lindsay Mayer, RN, BSN, CPHQ
Director, Programs
Vizient
Course reviewer(s)
Jim Lichauer, PharmD, BCPS, FASHP
PI Program Director, Pharmacy
Vizient
Lindsay Mayer, RN, BSN, CPHQ
Director, Programs
Vizient
Presenters
Jeannie Kelly, MD, MS
Assistant Professor of OBGYN
Division of Maternal Fetal Medicine
Washington University in St. Louis
Medical Director, Obstetrical Inpatient Services
Medical Director, C.A.R.E. in Pregnancy
Washington University in St. Louis
Tara Tinnin, MSW
Program Coordinator for Dr. Cynthia Rogers
Perinatal Behavioral Health Service
Washington University School of Medicine
Department of Psychiatry
Washington University School of Medicine
Department of Psychiatry
Joint Accreditation Statement:
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Designation Statements:
NURSING
This activity is designated for 1.00 hours.
Vizient, Inc. is approved by the California Board of Registered Nursing, Provider Number CEP12580, for 1.20 contact hours.
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-0000-20-033-L01-P
PHYSICIAN
Vizient, Inc. designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CEU
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).
Available Credit
- 1.00 ACPE Pharmacist
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.20 CBRN
- 1.00 General CE – Attendance